Company News
Glenmark Transfers Nebulizer Portfolio to Subsidiary for ₹223 Cr
Glenmark Pharmaceuticals Board approved transfer of Nebulizer brands/IP portfolio to wholly-owned subsidiary Glenmark Healthcare Ltd.
Transaction valued at ₹223 crore cash consideration, based on inde
